BESHAR LUKE M

CIK 00011921286 companiesROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001192128

Recent Transactions

50 trades

Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2024-06-07+10,000→ 10,000 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2023-06-07+10,000→ 10,000 total
Award
Omega Therapeutics, Inc.
Stock Option (Right to Buy)
2023-06-07+18,118→ 18,118 total
Purchase
Protara Therapeutics, Inc.$TARA
Common Stock
2022-06-30$3.10/sh+10,000→ 198,000 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2022-06-08+10,000→ 10,000 total
Award
Omega Therapeutics, Inc.
Option (Right to Buy)
2022-06-08+18,118→ 18,118 total
Purchase
Protara Therapeutics, Inc.$TARA
Common Stock
2022-03-14$4.25/sh+10,000→ 188,000 total
Purchase
Protara Therapeutics, Inc.$TARA
Common Stock
2022-03-10$4.46/sh+10,000→ 178,000 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−40,000→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Deferred Share Unit
2021-11-17−547,656.26→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−6,666→ 0 total
Award
Omega Therapeutics, Inc.
Stock Option (Right to Buy)
2021-07-29+52,941→ 52,941 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2021-06-09+10,000→ 10,000 total
Award
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2021-06-04+10,000→ 10,000 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2020-06-09+9,000→ 9,000 total
Award
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2020-05-29+10,000→ 10,000 total
Award
Protara Therapeutics, Inc.$TARA
Common Stock
2020-01-10+168,000→ 168,000 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2020-01-09+12,399→ 12,399 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2020-01-09+12,399→ 12,399 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2020-01-09+10,491→ 10,491 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2020-01-09+6,676→ 6,676 total
Award
Protara Therapeutics, Inc.$TARA
Stock Option (Right to Buy)
2020-01-09+6,676→ 6,676 total
Award
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2019-05-31+10,000→ 10,000 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Common Stock
2018-11-29$3.76/sh+12,784→ 12,784 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2018-11-29−12,784→ 53,000 total
Sale
REGENXBIO Inc.$RGNX
Common Stock
2018-11-29$65.00/sh−12,784→ 0 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Common Stock
2018-11-27$18.85/sh+6,250→ 11,820 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2018-11-27−716→ 65,784 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2018-11-27−6,250→ 0 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2018-11-27−4,687→ 0 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Common Stock
2018-11-27$3.76/sh+716→ 18,786 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Common Stock
2018-11-27$49.45/sh+883→ 883 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2018-11-27−883→ 7,292 total
Sale
REGENXBIO Inc.$RGNX
Common Stock
2018-11-27$65.03/sh−18,786→ 0 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2018-11-27−6,250→ 0 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Common Stock
2018-11-27$22.00/sh+4,687→ 5,570 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Common Stock
2018-11-27$12.74/sh+6,250→ 18,070 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Common Stock
2018-11-26$49.45/sh+1,721→ 1,721 total
Sale
REGENXBIO Inc.$RGNX
Common Stock
2018-11-26$65.00/sh−1,721→ 0 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2018-11-26−1,721→ 8,175 total
Sale
REGENXBIO Inc.$RGNX
Common Stock
2018-11-20$60.38/sh−21,176→ 0 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Common Stock
2018-11-20$12.74/sh+2,988→ 7,676 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2018-11-20−2,988→ 6,250 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2018-11-20−13,500→ 66,500 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2018-11-20−4,688→ 4,687 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Common Stock
2018-11-20$22.00/sh+4,688→ 4,688 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Common Stock
2018-11-20$3.76/sh+13,500→ 21,176 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Stock Option (Right to Buy)
2018-11-19−6,250→ 6,250 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Common Stock
2018-11-19$49.45/sh+2,604→ 2,604 total
Exercise/Conversion
REGENXBIO Inc.$RGNX
Common Stock
2018-11-19$12.74/sh+3,262→ 12,116 total

BESHAR LUKE M

Recent Transactions

Companies

Recent Filings

Address